Crown years for non-invasive cardiovascular imaging (Part III): 30 years cardiovascular magnetic resonance

Netherlands Heart Journal

Volumn 21, Issue 6, 2013, Pages 263-265

  van der Wall, E E ^a  

^a ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; GADOLINIUM PENTETATE; THALLIUM 201;

CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84878233572     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-013-0406-y     Document Type: Editorial

References (43)

1. van der Wall EE. Crown years for noninvasive cardiovascular imaging (part I): 60 years of echocardiography. Neth Heart J. 2013;21:161-2. doi:10.1007/s12471-013-0381-3.
2. van der Wall EE. Crown years for noninvasive cardiovascular imaging (part II): 40 years of nuclear cardiology. Neth Heart J. 2013. doi:10.1007/s12471-013-0392-0.
3. Kaufman L, Crooks L, Sheldon P, et al. The potential impact of nuclear magnetic resonance imaging on cardiovascular diagnosis. Circulation. 1983;67:251-7.
4. Pohost GM, Ratner AV, Okada RD. Proton NMR imaging: a new approach for the evaluation of cardiac structure and function. Int J Cardiol. 1983;4:87-94.
5. Higgins CB, Botvinick EH, Lanzer P, et al. Cardiovascular imaging with nuclear magnetic resonance. Cardiol Clin. 1983;1:527-39.
6. Steiner RE, Bydder GM, Selwyn A, et al. Nuclear magnetic resonance imaging of the heart. Current status and future prospects. Br Heart J. 1983;50:202-8.
7. Burdine JA, Murphy PH. Cardiac imaging by nuclear magnetic resonance. Tex Heart Inst J. 1983;10:45-8.
8. Waterton JC, Jenkins JP, Zhu XP, et al. Magnetic resonance (MR) cine imaging of the human heart. Br J Radiol. 1985;58:711-6.
9. van Rossum AC, Visser FC, van Eenige MJ, et al. Magnetic resonance imaging of the heart for determination of ejection fraction. Int J Cardiol. 1988;18:53-63.
10. Bavelaar-Croon CD, Kayser HW, van der Wall EE, et al. Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology. 2000;217:572-5.
11. de Roos A, Doornbos J, van der Wall EE, et al. MR imaging of acute myocardial infarction: value of Gd-DTPA. AJR Am J Roentgenol. 1988;150:531-4.
12. van Dijkman PR, van der Wall EE, de Roos A, et al. Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology. 1991;180:147-51.
13. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-53.
14. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250-8.
15. Germans T, Wilde AA, Dijkmans PA, et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol. 2006;48:2518-23.
16. Müller KA, Müller I, Kramer U, et al. Prognostic Value of Contrastenhanced Cardiac Magnetic Resonance Imaging in Patients with Newly Diagnosed Non-Ischemic Cardiomyopathy: Cohort Study. PLoS One. 2013;8:e57077. doi:10.1371/journal.pone.0057077.
17. Zerhouni EA, Parish DM, Rogers WJ, et al. Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion. Radiology. 1988;169:59-63.
18. Kuijer JP, Marcus JT, Götte MJ, et al. Variance components of twodimensional strain parameters in the left-ventricular heart wall obtained by magnetic resonance tagging. Int J Cardiovasc Imaging. 2001;17:49-60.
19. Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology. 1990;174:757-62.
20. Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med. 1996;35:221-8.
21. Edelman RR, Manning WJ, Burstein D, et al. Coronary arteries: breath-hold MR angiography. Radiology. 1991;181:641-3.
22. van derWall EE, Vliegen HW, de Roos A, et al. Magnetic resonance imaging in coronary artery disease. Circulation. 1995;92:2723-39.
23. Langerak SE, Vliegen HW, de Roos A, et al. Detection of vein graft disease using high-resolution magnetic resonance angiography. Circulation. 2002;105:328-33.
24. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992;70:34-40.
25. van Rugge FP, van der Wall EE, Spanjersberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation. 1994;90:127-38.
26. Kilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European society of cardiology. Eur Heart J. 2010;31:794-805. doi:10.1093/eurheartj/ehp586.
27. Joziasse IC, Vink A, Cramer MJ, et al. Bicuspid stenotic aortic valves: clinical characteristics and morphological assessment using MRI and echocardiography. Neth Heart J. 2011;19:119-25.
28. Rebergen SA, Ottenkamp J, Doornbos J, et al. Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol. 1993;21:123-31.
29. Groenink M, de Roos A, Mulder BJ, et al. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol. 1998;82:203-8.
30. Lexis CP, Rahel BM, van Langen H, et al. Cardiac magnetic resonance imaging in daily practice in a peripheral medical centre: description of the first 383 patients. Neth Heart J. 2010;18:524-30.
31. Luijkx T, Cramer MJ, Zaidi A, et al. Ethnic differences in ventricular hypertrabeculation on cardiac MRI in elite football players. Neth Heart J. 2012;20:389-95. doi:10.1007/s12471-012-0305-7.
32. Olimulder MA, Galjee MA, van Es J, et al. Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability. Neth Heart J. 2011;19:236-45. doi:10.1007/s12471-011-0084-6.
33. Freling HG, van Slooten YJ, van Melle JP, et al. Prosthetic valves in adult patients with congenital heart disease: Rationale and design of the Dutch PROSTAVA study. Neth Heart J. 2012;20:419-24.
34. Robbers LF, Nijveldt R, Beek AM, et al. Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe? Neth Heart J. 2012;20:133-7.
35. Corti R, Fuster V. Imaging of atherosclerosis: magnetic resonance imaging. Eur Heart J. 2011;32:1709-19. doi:10.1093/eurheartj/ehr068.
36. Marcu CB, Beek AM, Ionescu CN, et al. Double orifice mitral valve visualized on echocardiography and MRI. Neth Heart J. 2012;20:380-1. doi:10.1007/s12471-011-0149-6.
37. Schwitter J, Wacker CM, Wilke N, et al. Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. singlephoton emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34:775-81. doi:10.1093/eurheartj/ehs022.
38. van der Wall EE. Myocardial perfusion imaging in coronary artery disease: SPECT, PET or CMR? Neth Heart J. 2012;20:297-8. doi:10.1007/s12471-012-0300-z.
39. Rischpler C, Nekolla SG, Dregely I, et al. Hybrid PET/MR Imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med. 2013;54:402-15. doi:10.2967/jnumed.112.105353.
40. Underwood SR, Bax JJ, Vom Dahl J, et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J. 2004;25:815-36.
41. Gerber BL, Raman SV, Nayak K, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson. 2008;10:18. doi:10.1186/1532-429X-10-18.
42. Charoenpanichkit C, Hundley WG. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:59. doi:10.1186/1532-429X-12-59.
43. Kirschbaum SW, de Feyter PJ, van Geuns RJ. Cardiac magnetic resonance imaging in stable ischaemic heart disease. Neth Heart J. 2011;19:229-35. doi:10.1007/s12471-011-0106-4.